Cathelicidin antimicrobial peptide LL-37 in cholesteatoma enables keratinocyte reactivity with cytosolic DNA

Z Chi1, Z Wang, K Wang

  • 1Department of Otolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China.

Insights

Self-DNA triggers inflammation in cholesteatoma by activating keratinocytes. The antimicrobial peptide LL-37 plays a key role in this DNA-triggered inflammatory response, suggesting new therapeutic targets.

Area of Science:

  • Immunology
  • Otolaryngology
  • Dermatology

Background:

  • Cholesteatoma is a destructive epithelial growth in the middle ear.
  • The role of self-DNA in cholesteatoma-associated inflammation is not well understood.

Purpose of the Study:

  • To investigate if self-DNA can initiate inflammatory responses in cholesteatoma.
  • To explore the involvement of LL-37 and interferon-alpha in this process.

Main Methods:

  • Immunofluorescence and immunoblot analysis of patient specimens.
  • In vitro culture of cholesteatoma keratinocytes exposed to DNA and LL-37.
  • RT-PCR to detect interferon-alpha expression.

Main Results:

  • Abundant cytosolic DNA, increased LL-37, and interferon-alpha were found in invasive and perforated attic-type cholesteatoma keratinocytes.
  • LL-37-DNA complexes induced interferon-alpha expression in cultured keratinocytes.
  • These inflammatory markers were absent in intact attic-type cholesteatoma and healthy skin.

Conclusions:

  • Cytosolic DNA acts as a disease-associated molecular pattern triggering inflammation in cholesteatoma.
  • LL-37 is crucial in mediating DNA-induced inflammation.
  • The interplay between cytosolic DNA, LL-37, and autoinflammation offers potential therapeutic targets for cholesteatoma.

Related Concept Videos